SCHEMBL4354284

SCHEMBL4354284

COc1ccc(C2=NNC3(S2)C(=O)Nc2ccc(C)cc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 19/20 1.00
ALDH1A1 P00352 2/20 0.65
LMNA P02545 2/20 0.65
MAPT P10636 2/20 0.65
HTT P42858 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
L3MBTL1 Q9Y468 2/20 0.65
KDM4E B2RXH2 1/20 0.65
TP53 P04637 1/20 0.65
HPGD P15428 1/20 0.65
MMP12 P39900 1/20 0.64
ADAMTS4 O75173 1/20 0.61
SLC27A2 O14975 1/20 0.55
MEN1 O00255 1/20 0.55
XBP1 P17861 1/20 0.55
MAPK1 P28482 1/20 0.55
MDM2 Q00987 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351324 0.92 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4980986 0.92 ADAMTS5 (0.84) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4343954 0.90 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL24571121 0.87 ADAMTS5 (0.78) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4980994 0.87 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4983286 0.87 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4352205 0.86 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4354096 0.85 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL4347482 0.85 ADAMTS5 (1.00) ADAMTS5ALDH1A1LMNAMAPTHTT
SCHEMBL22571240 0.85 ADAMTS5 (0.87) ADAMTS5ALDH1A1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032584-A2 THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF Wyeth (US) 2009-03-11 EP claimed
US-20080125469-A1 Thiadiazole compounds and methods of use thereof WYETH (US) 2008-05-29 US claimed
WO-2007146138-A2 THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF WYETH (US) 2007-12-21 WO claimed
US-20080125469-A1 Thiadiazole compounds and methods of use thereof WYETH (US) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125469-A1 Thiadiazole compounds and methods of use thereof ADAMTS5, ADAMTS1, TIMP3 ADAMTS5 1/4885ALDH1A1 388/4885LMNA 4000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.